378 related articles for article (PubMed ID: 27726412)
1. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images.
Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A
AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412
[TBL] [Abstract][Full Text] [Related]
2. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
3. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
4. Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.
Anwar M; Molinaro AM; Morin O; Chang SM; Haas-Kogan DA; Nelson SJ; Lupo JM
Radiat Res; 2017 Sep; 188(3):303-313. PubMed ID: 28723274
[TBL] [Abstract][Full Text] [Related]
5. Prediction of recurrent glioblastoma after laser interstitial thermal therapy: The role of diffusion imaging.
Mahammedi A; Bachir S; Escott EJ; Barnett GH; Mohammadi AM; Larvie M
Neurooncol Adv; 2019; 1(1):vdz021. PubMed ID: 32642657
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the apparent diffusion coefficient in patients with recurrent glioblastoma under treatment with bevacizumab with radiographic pseudoresponse.
Auer TA; Breit HC; Marini F; Renovanz M; Ringel F; Sommer CJ; Brockmann MA; Tanyildizi Y
J Neuroradiol; 2019 Feb; 46(1):36-43. PubMed ID: 29733920
[TBL] [Abstract][Full Text] [Related]
7. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme.
Elson A; Paulson E; Bovi J; Siker M; Schultz C; Laviolette PS
J Neurooncol; 2015 May; 123(1):179-88. PubMed ID: 25894597
[TBL] [Abstract][Full Text] [Related]
9. Infiltrative patterns of glioblastoma: Identification of tumor progress using apparent diffusion coefficient histograms.
Lutz K; Wiestler B; Graf M; Bäumer P; Floca R; Schlemmer HP; Heiland S; Wick W; Bendszus M; Radbruch A
J Magn Reson Imaging; 2014 May; 39(5):1096-103. PubMed ID: 24115401
[TBL] [Abstract][Full Text] [Related]
10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
11. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
Wang P; Shi YH; Li JY; Zhang CZ
World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
[TBL] [Abstract][Full Text] [Related]
13. Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Ellingson BM; Cloughesy TF; Lai A; Mischel PS; Nghiemphu PL; Lalezari S; Schmainda KM; Pope WB
Neuro Oncol; 2011 Oct; 13(10):1151-61. PubMed ID: 21856685
[TBL] [Abstract][Full Text] [Related]
14. Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme.
Paldino MJ; Barboriak D; Desjardins A; Friedman HS; Vredenburgh JJ
J Magn Reson Imaging; 2009 May; 29(5):1199-205. PubMed ID: 19388113
[TBL] [Abstract][Full Text] [Related]
15. Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.
Buemi F; Guzzardi G; Del Sette B; Sponghini AP; Matheoud R; Soligo E; Trisoglio A; Carriero A; Stecco A
Neuroradiol J; 2019 Aug; 32(4):241-249. PubMed ID: 31066622
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab.
Ellingson BM; Cloughesy TF; Lai A; Nghiemphu PL; Pope WB
Magn Reson Med; 2012 Jan; 67(1):237-45. PubMed ID: 21702063
[TBL] [Abstract][Full Text] [Related]
17. Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery.
Zolal A; Juratli TA; Linn J; Podlesek D; Sitoci Ficici KH; Kitzler HH; Schackert G; Sobottka SB; Rieger B; Krex D
J Neurooncol; 2016 May; 127(3):551-7. PubMed ID: 26830088
[TBL] [Abstract][Full Text] [Related]
18. A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies.
Chang PD; Malone HR; Bowden SG; Chow DS; Gill BJA; Ung TH; Samanamud J; Englander ZK; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Schwartz LH; Lignelli A; Grinband J; Bruce JN; Canoll P
AJNR Am J Neuroradiol; 2017 May; 38(5):890-898. PubMed ID: 28255030
[TBL] [Abstract][Full Text] [Related]
19. Increase in FLAIR Signal of the Fluid Within the Resection Cavity as Early Recurrence Marker: Also Valid for Brain Metastases?
Bette S; Gempt J; Wiestler B; Huber T; Specht H; Meyer B; Zimmer C; Kirschke JS; Boeckh-Behrens T
Rofo; 2017 Jan; 189(1):63-70. PubMed ID: 28002859
[No Abstract] [Full Text] [Related]
20. Utility of tubular retractors to minimize surgical brain injury in the removal of deep intraparenchymal lesions: a quantitative analysis of FLAIR hyperintensity and apparent diffusion coefficient maps.
Bander ED; Jones SH; Kovanlikaya I; Schwartz TH
J Neurosurg; 2016 Apr; 124(4):1053-60. PubMed ID: 26430838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
